Cancers, Vol. 11, Pages 1862: Minimal Effect of Bevacizumab Treatment on Residual Vestibular Schwannomas after Partial Resection in Young Neurofibromatosis Type 2 Patients
In conclusion, our comprehensive follow-up on 16 VS in nine NF2 patients did show heterogenous effects of bevacizumab on small residual vestibular schwannomas after surgery both regarding tumor size and hearing preservation. Thus, smaller and slower growing tumor residuals seem to behave differently to bevacizumab than reported for not-operated faster growing VS.
Source: Cancers - Category: Cancer & Oncology Authors: Isabel Gugel Lan Kluwe Julian Zipfel Christian Teuber Marcos Tatagiba Victor-Felix Mautner Martin Ulrich Schuhmann Florian Grimm Tags: Article Source Type: research
More News: Avastin | Brain | Cancer | Cancer & Oncology | Cancer in Adolescents | Children | Neurofibromatosis | Neurology | Neurosurgery | Study